Mesothelial cell gene therapy

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424572, 435366, 435371, 435455, 514 44, C12N 1500, C12N 500, A61K 4800, A01N 6300

Patent

active

060688378

ABSTRACT:
Methods and pharmaceutical compositions for modifying the mesothelial cells of a mammalian recipient in situ are provided. The methods include forming a mesothelial cell expression system in vivo or ex vivo and administering the expression system to the mammalian recipient (by way of the body cavities normally lined by mesothelial cells). The mesothelial cell expression system is useful for the localized and systemic delivery of therapeutic agents in situ.

REFERENCES:
patent: 4755593 (1988-07-01), Lauren
patent: 4885238 (1989-12-01), Reddel et al.
patent: 5399346 (1995-03-01), Nih
patent: 5645829 (1997-07-01), Shockly et al.
Anderson WF, Nature 392:25-30, 1998.
Verma et al Nature 389:239-242, 1997.
Touchette, Nat. Med. 2(1) 7-8, 1996.
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy, 1995.
Selden et al, Science, 236:714-718, 1987.
Nagy et al, Gene Therapy 2:393-401 1995.
Pronk et al, Cell Transplantataion, 3(1):41-48 1994.
Nagy et al, Gene Therapy, 2:402-410, 1995.
Sandrin et al, PNAS 90:11391-11395, 1993.
Brody, S. and R. Crystal, Adenovirus-mediated in vivo gene transfer, Annals of the New York Academy of Sciences, vol. 716, May 31, 1994, pp 90-103.
Danos, O. et al., Reimplantation de cellules genetiquement modifiees dans des neo-organes vascularises, Medicine Sciences, vol. 9, No. 2, Feb. 1993, pp 208-210.
Nagy, J.A. et al., Mesothelial cell gene therapy, Journal of Cellular Biochemistry, Supplement 18A, Jan., 1994, p. 244.
Setoguchi Y. et al., In vivo gene therapy targeting the peritoneum for .alpha.1-antitrypsin deficiency, American Review of Respiratory Diseases, vol. 147, No. 4, Apr., 1993, p A546.
Setoguchi Y. et al., Stimulation of erythropoieses by in vivo gene therapy: physiologic consequence of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector, Clinical Research, vol. 41, No. 2, Apr. 1993, p. 259A.
Brody, S. et al., In-vivo gene transfer to malignant mesothelioma using an adenovirus vector, 1992 International Conference of the American Lung Association and the American Thoracic Society, Miami Beach, FL May 17-20, 1992, Am. Rev. Respir Dis 145 (4 part 2) 1992 A425.
Rosenberg, S.A., et al., New Eng. J. Med., 323:570-578 (1990), "Gene Transfer Into Humans--Immunotherapy of Patients With Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified By Retroviral Gene Transduction".
Anderson, W.F., Human Gene Therapy 2: 99-100 (1991), Editorial "Steady Process".
Anderson, W.F., "Human Gene Therapy", Science 256: 808-813 (1992).
Miller, A.D., "Human Gene Therapy Comes of Age", Nature 357: 455-460 (1992).
Felgner, P.L. and Rhodes, G., Nature 349:351-352 (1991), "Gene Therapeutics".
DiPaolo, N., Perit. Dial. Int. 9: 151-153 (1989), Editorial "The Peritoneal Mesothelium: An Excretory Organ".
Dobbie, J.W., Perit. Dial. Int. 8: 3-6 (1988), Editorial "From Philosopher to Fish: The Comparative Anatomy of the Peritoneal Cavity as an Excretory Organ and its Significance for Peritoneal Dialysis in Man".
DiPaolo, N., et al., "Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient" Int. J. Art. Org. 12: 485-501 (1989).
DiPaolo, N., et al., "Autologous implant of peritoneal mesothelium in rabbits and man", Clinical Nephrol 34: 179-184 (1990).
DiPaolo, N., et al., "Autologous Peritoneal Mesothelial Cell Implant in Rabbits and Peritoneal Dialysis Patients", Nephron 57: 323-331 (1991).
Stylianou, E., et al., "Isolation, culture and characterization of human peritoneal mesothelial cells", Kidney Intl. 37: 1563-1570 (1990).
Pronk, A., et al., In Vitro Cell. Dev. Biol. 29A: 127-134 (1993), "A Cobblestone Cell Isolated From The Human Omentum: The Mesothelial Cell; Isolation, Identification, and Growth Characteristics".
Roemer, K. and Friedmann, T., "Concepts and Strategies for Human Gene Therapy", Eur. J. Biochem. 208: 211-225 (1992).
Brash D.E., et al., Molec. Cell. Biol. 7: 2031-2034 (1987), "Strontium Phosphate Transfection of Human Cells in Primary Culture: Stable Expression of the Simian Virus 40 Large-T-Antigen Gene in Primary Human Bronchial Epithelial Cells".
Lechner et al., Proc. Natl. Acad. Sci. U.S.A. 82: 3884-3888 (1985) "Asbestos-associated chromosomal changes in human mesothelial cells".
Yang Ke, et al., ":Establishment of a Human In Vitro Mesothelial Cell Model System for Investigating Mechanisms of Asbestos-Induced Mesothelioma", Amer. J. Pathology 134: 979-991 (1989).
Rheinwald, J., et al., Neoplastic Transformation in Human Cell Culture, Eds: J.S. Rhim and A. Dritschilo The Humana Press, Inc. Totowa, N.J. (1991), "Mitogen-Independence and Autocrine Growth Factor Secretion Displayed by Human Mesothelioma Cells and Oncogene-Transfected Mesothelial Cells".
Temin, "Retrovirus vectors for gene transfer", Gene Transfer, Kucherlapati R., Ed., pp 149-187, Plenum (1986).
Aronson, J.F., et al., Lab. Invest. 34: 529-536 (1976), "Initiation of Lung Cell Proliferation by Trypsin".
Esperanca, M.J. and Collins, D.L., J. Ped. Surg. 1: 162-169 (1966) "Peritoneal Dialysis Efficiency in Relation to Body Weight".
Rubin, B.J., et al., Am. J. Med. Sci. 295: 453-458 (1988), "Measurements of Peritoneal Surface Area in Man and Rat".
Larrick, J.W. and Burck, K.L., Gene Therapy Application of Molecular Biology, Elsevier Science Publishing Co., Inc., New York, p 71-104 (1991) "Gene Transfer: Introduction of DNA into Cells Using Physical and Biological Methods".
Rosenfield, M.A., et al., Science 252: 431-434 (1991), "Adenovirus-Mediated Transfer of a Recombinant .alpha.1-Antitrypsin Gene to the Lung Epithelium in Vivo".
Hjelle, J.T., et al., Peritoneal Dialysis International, vol. 9, pp. 341-347, 1989, "Isolation and Propagation in Vitro of Peritoneal Mesothelial Cells".
Heldin, P., Biochem J. 283: 165-170 (1992), "Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells".
Price, J. et al., Proc. Natl. Acad. Sci. USA 84: 156-160 (1987), "Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer".
Riese K.H., et al., Path. Res. Pract. 162: 327-336 (1978).
Chung-Welch, N., et al., Differentiation 42: 44-53 (1989), "Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential".
Wu, Y.J., et al., Cell 31: 693-703 (1982), "The Mesothelial Keratins: A New Family of Cytoskeletal Proteins Identified in Cultured Mesothelial Cells and Nonkeratinizing Epithelia".
Blaese, R. Michael, "Progress Toward Gene Therapy", Clinical Immunology and Immunpatholopy 61, S47-S55 (1991).
Rheinwald, J.G., Baserga, R., Editor, Cell Growth and Division: a practical approach, IRL Press, Oxford England, pp. 81-94 (1989), "Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells".
Bull, H.A., et al., "Effects of autologous mesothelial cell seeding on prostacyclin production within Dacron arterial prostheses", Br. J. Surg., vol. 75, 671-674, Jul. 1988.
Kay, Mark A., et al., "Human gene therapy: present and future", Breast Cancer Research and Treatment 21: 83-93, 1992.
Rheinwald, J., et al., "Mitogen-Independence and Autocrine Growth Factor Secretion Displayed by Human Mesothelioma Cells and Oncogene-Transfected Mesothelial Cells", pp 359-366.
Reddel, R., et al., "Tumorigenicity of Human Mesothelial Cell Line Transfected with EJ-ras Oncogene", vol. 81, No. 12, Jun. 21, 1989, pp 945-948.
Luzzatto, L. Journal of Internal Medicine, 1992:231: 3-6, "Frontiers in medicine Gene transfer and gene therapy".
Cheng, H., et al., Dept. Of Anatomy, McGill University, Montreal, Canada, "A Technique For the Preparation of Monolayers of Mesothelium".
Watters, W.B., et al., Virchows Arch. Abt. B. Zellpath, 13, 48-54 (1973), "Mitotic Activity of Peritoneum in Contact with a Regenerating Area of Peritoneum".
Palmer, et al., Blood 73 (2): 438-445 (1989).
Recombinant DNA Advisory Committee (RAC) Data M

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mesothelial cell gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mesothelial cell gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mesothelial cell gene therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1908117

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.